To this date, POLE mutations have been found to be the germline predisposition factor in families with multiple adenomas and early-onset CRC [11–16], as well as in other neoplasms such as endometrial, ovarian, brain, pancreas, small intestine and cutaneous melanoma [15, 17–19]. Here, POLE is linked to neoplasm.